15-58749813-T-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001110.4(ADAM10):c.-279A>T variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001110.4 upstream_gene
Scores
Clinical Significance
Conservation
Publications
- reticulate acropigmentation of KitamuraInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001110.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ADAM10 | NM_001110.4 | MANE Select | c.-279A>T | upstream_gene | N/A | NP_001101.1 | |||
| ADAM10 | NM_001320570.2 | c.-279A>T | upstream_gene | N/A | NP_001307499.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ADAM10 | ENST00000260408.8 | TSL:1 MANE Select | c.-279A>T | upstream_gene | N/A | ENSP00000260408.3 | |||
| ADAM10 | ENST00000402627.5 | TSL:1 | c.-279A>T | upstream_gene | N/A | ENSP00000386056.1 | |||
| ADAM10 | ENST00000559053.1 | TSL:4 | c.-279A>T | upstream_gene | N/A | ENSP00000453952.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 16
GnomAD4 genome Cov.: 30
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at